Gastrointestinal (GI) distress in endurance athletes is prevalent and detrimental to performance. Adverse GI symptomatology can be analogous with irritable bowel syndrome, where fermentable oligosaccharide, disaccharide, monosaccharide, and polyols (FODMAP) reduction has demonstrated efficacy. This study investigated the effects of low FODMAP (LFOD) diet on GI distress parameters in runners with a history of nonclinical exercise-associated GI symptoms.
Eleven recreationally competitive runners (five men, six women; 5-km personal best 23:00 ± 4:02 min:s) participated in the study. Runners were allocated to a randomized 6-d LFOD or high FODMAP (HFOD) diet separated by a 1-d wash-out in a controlled, single-blinded cross-over study. In each period participants completed two strenuous running sessions consisting of 5 × 1000 m and a 7-km threshold run. GI symptoms (during-exercise and daily) and the Daily Analysis of Life Demand for Athletes questionnaires were completed. Area under the curve was calculated for daily GI symptoms across each dietary period and analysis was conducted using multilevel mixed-effects linear regression for comparison between the two diets.
A significantly smaller area under the curve for daily GI symptoms 6 d during the LFOD compared with HFOD (mean difference, −13.4; 95% confidence interval, −22 to −4.60; P = 0.003) was observed. The daily GI symptoms that were significantly lower during LFOD were flatulence (P < 0.001), urge to defecate (P = 0.04), loose stool (P = 0.03), and diarrhea (P = 0.004). No significant differences in during exercise symptoms or Daily Analysis of Life Demand for Athletes responses were observed between diets (P > 0.05).
Preliminary findings suggest that short-term FODMAP reduction may be a beneficial intervention to minimize daily GI symptoms in runners with exercise-related GI distress.
1 Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Launceston, Tasmania, AUSTRALIA; and 2Canadian Sports Institute-Pacific, Victoria, British Columbia, CANADA
Address for correspondence: Dana M. Lis, Ph.D., R.D., C.S.S.D., School of Health Sciences, University of Tasmania, Locked Bag 1322, Launceston, Tasmania 7250, Australia; E-mail: Dana.Lis@utas.edu.au.
Submitted for publication February 2017.
Accepted for publication August 2017.